Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for NeuBase Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-03-30
Purchase
2022-04-01
4:16 pm
NeuBase Therapeutics Inc. NBSE Mann William Roland
Chief Operating Officer
6,200 $1.92 $11,904 11,200
(Direct)
View
2022-03-18
Purchase
2022-03-21
4:06 pm
NeuBase Therapeutics Inc. NBSE Branning Todd P.
CFO
10,000 $1.81 $18,100 30,000
(Direct)
View
2022-03-16
Purchase
2022-03-18
4:11 pm
NeuBase Therapeutics Inc. NBSE Branning Todd P.
CFO
20,000 $1.68 $33,600 20,000
(Direct)
View
2022-03-01
Purchase
2022-03-07
7:13 pm
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
3,880 $1.6372 $6,352 72,707
(Indirect
Direct)
View
2021-06-18
Purchase
2021-06-21
11:03 am
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
8,000 $4.75 $38,000 30,000
(Direct)
View
2021-04-26
Purchase
2021-04-27
4:03 pm
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
5,000 $5 $25,000 68,827
(Indirect
Direct)
View
2021-04-26
Purchase
2021-04-27
4:03 pm
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
12,000 $5 $60,000 1,298,344
(Indirect
Direct)
View
2021-04-26
Purchase
2021-04-27
4:02 pm
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
12,000 $5 $60,000 22,000
(Direct)
View
2021-04-26
Purchase
2021-04-27
4:01 pm
NeuBase Therapeutics Inc. NBSE Mann William Roland
COO
5,000 $5 $25,000 5,000
(Direct)
View
2020-06-09
Purchase
2020-06-10
11:50 am
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
Lipizzaner LLC
CEO
10% Owner
1,275 $7.7339 $9,861 2,560,164
(Indirect
Direct)
View
2020-05-21
Purchase
2020-05-26
4:39 pm
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
Lipizzaner LLC
CEO
10% Owner
1,250 $8.0888 $10,111 2,558,889
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-24
Option Award
2022-01-25
2:03 pm
N/A
2032-01-24
NeuBase Therapeutics Inc. NBSE Mann William Roland
Chief Operating Officer
60,180 $0 60,180
(Direct)
View
2022-01-24
Option Award
2022-01-25
2:00 pm
N/A
2032-01-24
NeuBase Therapeutics Inc. NBSE Rojas-Caro Sandra
Chief Medical Officer
44,592 $0 44,592
(Direct)
View
2022-01-24
Option Award
2022-01-25
1:50 pm
N/A
2032-01-24
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
306,000 $0 306,000
(Direct)
View
2022-01-10
Option Award
2022-01-10
7:19 pm
N/A
2032-01-10
NeuBase Therapeutics Inc. NBSE Branning Todd P.
CFO
300,000 $0 300,000
(Direct)
View
2021-12-31
Exercise
2022-01-05
9:45 pm
2019-07-12
2028-12-31
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
42,250 $0.001 4,610,274
(Direct)
View
2022-01-01
Option Award
2022-01-05
4:05 pm
N/A
2032-01-01
NeuBase Therapeutics Inc. NBSE Ende Eric J
Director
165,803 $0 165,803
(Direct)
View
2021-08-16
Option Award
2021-09-24
5:03 pm
N/A
2031-08-16
NeuBase Therapeutics Inc. NBSE Mann William Roland
COO
25,000 $0 25,000
(Direct)
View
2021-08-19
Option Award
2021-09-17
4:17 pm
N/A
2031-08-19
NeuBase Therapeutics Inc. NBSE McDougall Gerald J
Director
38,135 $0 38,135
(Direct)
View
2021-08-19
Option Award
2021-09-17
4:17 pm
N/A
2031-08-19
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
38,135 $0 38,135
(Direct)
View
2021-08-19
Option Award
2021-09-17
4:17 pm
N/A
2031-08-19
NeuBase Therapeutics Inc. NBSE PRENDERGAST FRANKLYN G
Director
38,135 $0 38,135
(Direct)
View
2021-08-19
Option Award
2021-09-17
4:16 pm
N/A
2031-08-19
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
38,135 $0 38,135
(Direct)
View
2021-05-24
Option Award
2021-05-25
4:13 pm
N/A
2031-05-24
NeuBase Therapeutics Inc. NBSE Rojas-Caro Sandra
Chief Medical Officer
280,000 $0 280,000
(Direct)
View
2021-05-24
Option Award
2021-05-25
4:12 pm
N/A
2031-05-24
NeuBase Therapeutics Inc. NBSE Motesharei Kianoush
See Remarks
250,000 $0 250,000
(Direct)
View
2021-05-11
Option Award
2021-05-13
6:03 pm
N/A
2031-05-11
NeuBase Therapeutics Inc. NBSE McDougall Gerald J
Director
92,219 $0 92,219
(Direct)
View
2020-12-29
Gift
2020-12-30
5:01 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
6,369,097 $0 1,451,269
(Indirect)
View
2020-12-29
Option Award
2020-12-30
5:01 pm
N/A
2030-12-29
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
164,925 $0 1,451,269
(Direct)
View
2020-12-29
Option Award
2020-12-30
5:01 pm
N/A
2030-12-29
NeuBase Therapeutics Inc. NBSE Backenroth Samuel
CFO
41,915 $0 41,915
(Direct)
View
2020-12-01
Option Award
2020-12-02
09:46 am
N/A
2030-12-01
NeuBase Therapeutics Inc. NBSE Bradshaw Curt
Chief Scientific Officer
250,000 $0 250,000
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:20 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
14,634 $0 14,634
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:20 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE Miralles Gines Diego
Director
14,634 $0 14,634
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:20 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
14,634 $0 14,634
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:19 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE PRENDERGAST FRANKLYN G
Director
14,634 $0 14,634
(Direct)
View
2020-07-27
Option Award
2020-07-28
4:22 pm
N/A
2030-07-27
NeuBase Therapeutics Inc. NBSE Mann William Roland
COO
175,000 $0 175,000
(Direct)
View
Goto 0, 1, Next